Format

Send to

Choose Destination
J Clin Med. 2019 Jan 18;8(1). pii: E117. doi: 10.3390/jcm8010117.

The Future State of Newborn Stem Cell Banking.

Author information

1
Scientific and Medical Affairs, Cbr Systems Inc., 611 Gateway Blvd, Suite 820, South San Francisco, CA 94080, USA. kbrown@cordblood.com.
2
Collaborative Science Chair, InSTEM, Bangalore 560065, India. rao1789@gmail.com.
3
Scientific and Medical Affairs, Cbr Systems Inc., 611 Gateway Blvd, Suite 820, South San Francisco, CA 94080, USA. hbrown@cordblood.com.

Abstract

Newborn stem cell banking began with the establishment of cord blood banks more than 25 years ago. Over the course of nearly three decades, there has been considerable evolution in the clinical application of stem cells isolated from newborn tissues. The industry now finds itself at an inflection point as personalized medicine and regenerative medicine continue to advance. In this review, we summarize our perspective on newborn stem cell banking in the context of the future potential that stem cells from perinatal tissues are likely to play in nascent applications. Specifically, we describe the relevance of newborn stem cell banking and how the cells stored can be utilized as starting material for the next generation of advanced cellular therapies and personalized medicine.

KEYWORDS:

newborn stem cells; perinatal stem cells; placenta; stem cell banking; umbilical cord blood; umbilical cord tissue

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center